Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Eurofins Scientific SA News

    61,00 $ -0,20% -0,125 $
    In : 56,901 € | 15:36:37 Uhr Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2QJCT
    ISIN: FR0014000MR3
    US-Symbol: ERFSF
    Typ: Aktie

    Unternehmensmeldungen

    24.04.24 - Businesswire
    Eurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its Objectives
    Regulatory News:
    05.04.24 - Businesswire
    Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2024
    Regulatory News:
    03.04.24 - Businesswire
    The Eurofins Network Expands Its Offering in Renal and Transplant Testing in the United States With the Acquisition of Ascend Clinical LLC
    Regulatory News:
    25.03.24 - Businesswire
    Eurofins: Purchases of Own Shares from the 18th to the 22th of March 2024
    Regulatory News:
    25.03.24 - Businesswire
    Eurofins: Convening Notice of the Shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting of the Company Valid as an Information Notice for the Bondholders
    Regulatory News:
    18.03.24 - Businesswire
    Eurofins: Purchases of Own Shares From the 11th to the 15th of March 2024
    Regulatory News:
    12.03.24 - Businesswire
    Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 29 February 2024
    ANNEXE B
    11.03.24 - Businesswire
    Eurofins: Purchases of Own Shares From the 5th to the 8th of March 2024
    Regulatory News:
    29.02.24 - Businesswire
    Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets
    Eurofins Discovery , an industry-​leading provider of products and services for drug discovery research, today announced the launch of DiscoveryAI SAFIRE ( S uite of A DMET ...
    29.02.24 - Businesswire
    Eurofins E&E and ETS-Lindgren Complete Half-Million-Dollar Expansion to Silicon Valley EMC Testing Facility
    Eurofins MET Labs , part of the global Eurofins (Paris:ERF) network of companies, and a leader in product safety approvals and regulatory certification, is proud to announce the ...
    29.02.24 - Businesswire
    Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets
    Regulatory News:
    27.02.24 - Businesswire
    Eurofins Delivers Strong Margin Improvement and Cash Generation in H2 2023 and Annual Results in Line With Its 2023 Objectives. Remains Confident to Achieve Its 2027 Objectives.
    Regulatory News:
    20.02.24 - Businesswire
    Eurofins MET Labs Recognized for Instrumental Support in Intuitive Machines’ IM-1 Lunar Mission
    Eurofins MET Labs, part of the global network of Eurofins (Paris:ERF) laboratories and a global leader in product safety approvals and regulatory certification, has been officially ...
    19.02.24 - Businesswire
    Eurofins: Purchases of Own Shares from the 12th to the 14th of February 2024
    Regulatory News:
    12.02.24 - Businesswire
    Eurofins Scientific SE: Purchases of Own Shares from the 5th to the 9th of February 2024
    Regulatory News:
    07.02.24 - Businesswire
    Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 January 2024
    Regulatory News:
    05.02.24 - Businesswire
    Eurofins: Purchases of Own Shares From the 29th of January to the 2nd of February 2024
    Regulatory News:
    02.02.24 - Businesswire
    Eurofins Environment Testing in Sacramento, CA in Partnership with EPA Region 10 and EPA’s Office of Water Published Draft Method 1634, an Analytical Procedure to Test for 6PPD-Quinone in Surface and Stormwater
    Eurofins Environment Testing in Sacramento, California in partnership with EPA Region 10 worked with EPA’s Office of Water to publish Draft Method 1634, an analytical procedure to ...
    29.01.24 - Businesswire
    Eurofins: Purchases of Own Shares From the 22th of January to the 26th of January 2024
    Regulatory News:
    04.10.12 - GlobeNewswire
    ABLYNX REPORTS EXCELLENT INTERIM RESULTS FROM PHASE I/II STUDY WITH ITS ANTI-IL-6R NANOBODY, ALX-0061, IN RHEUMATOID ARTHRITIS PATIENTS
    ABLYNX REPORTS EXCELLENT INTERIM RESULTS FROM PHASE I/II STUDY WITH ITS ANTI-IL-6R NANOBODY, ALX-0061, IN RHEUMATOID ARTHRITIS PATIENTS 60% of ...

    Newssuche

    Videos

    09:30 Uhr +44,72%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »